Clinical TrialsRoche Stops Emugrobart in SMA and FSHD Trials After Weak Functional Outcome... Roche Stops Emugrobart in SMA and FSHD Trials After Weak Functional Outcome... Read Post »
GenericsIndia’s Semaglutide Generic Boom: The Race for Market Dominance Follo... India’s Semaglutide Generic Boom: The Race for Market Dominance Follo... Read Post »
Clinical TrialsBiohaven Completes Enrollment in Phase 2 Trial of Taldefgrobep for Obesity Biohaven Completes Enrollment in Phase 2 Trial of Taldefgrobep for Obesity Read Post »
WellnessShionogi Launches ZURZUVAE (Zuranolone) in Japan for Major Depressive Disor... Shionogi Launches ZURZUVAE (Zuranolone) in Japan for Major Depressive Disor... Read Post »
GenericsNATCO Rolls Out Affordable Generic Semaglutide for Type 2 Diabetes in India NATCO Rolls Out Affordable Generic Semaglutide for Type 2 Diabetes in India Read Post »
Health TidingsVanda Says FDA Draft on New Approach Methodologies Lacks Clarity Vanda Says FDA Draft on New Approach Methodologies Lacks Clarity Read Post »
Clinical TrialsBiogen-Eisai’s LEQEMBI Shows Strong Real-World Treatment Persistence ... Biogen-Eisai’s LEQEMBI Shows Strong Real-World Treatment Persistence ... Read Post »
Clinical TrialsSerum Institute Taps Eveliqure Platform for Anti-Diarrhoeal Vaccines in Chi... Serum Institute Taps Eveliqure Platform for Anti-Diarrhoeal Vaccines in Chi... Read Post »
Health Tidings Policy & AcquisitionsOxford, Serum Institute Partner to Advance ChAdOx1 Nipah Vaccine Oxford, Serum Institute Partner to Advance ChAdOx1 Nipah Vaccine Read Post »
New Drug ApprovalNivolumab Plus AVD Approved by FDA as Frontline Therapy for Advanced cHL Nivolumab Plus AVD Approved by FDA as Frontline Therapy for Advanced cHL Read Post »
Health TidingsMHRA and NICE Launch Aligned Pathway to Speed Access to New Medicines MHRA and NICE Launch Aligned Pathway to Speed Access to New Medicines Read Post »
Health TidingsGalimedix Reports Improved PK Profile for Next-Generation Oral Aβ Modulato... Galimedix Reports Improved PK Profile for Next-Generation Oral Aβ Modulato... Read Post »
New Drug ApprovalFDA Approves IMCIVREE as First Therapy for Acquired Hypothalamic Obesity FDA Approves IMCIVREE as First Therapy for Acquired Hypothalamic Obesity Read Post »
Health Tidings Policy & AcquisitionsNovartis Targets PIK3CA-Mutant Tumors With $3B Synnovation Deal for SNV4818 Novartis Targets PIK3CA-Mutant Tumors With $3B Synnovation Deal for SNV4818 Read Post »
Health TidingsCARDAMYST™ Nasal Spray Off to a Strong Start in the U.S., Milestone Repor... CARDAMYST™ Nasal Spray Off to a Strong Start in the U.S., Milestone Repor... Read Post »
Clinical TrialsChugai Files in Japan for Ocular Implant Component of Ranibizumab Port Deli... Chugai Files in Japan for Ocular Implant Component of Ranibizumab Port Deli... Read Post »
GenericsGlenmark Launches Milnacipran an Authorized Generic of Savella in the U.S.,... Glenmark Launches Milnacipran an Authorized Generic of Savella in the U.S.,... Read Post »
Health TidingsNew Biotech Kalohexis Targets Metabolic ‘Thermostat’ to Treat Obesity a... New Biotech Kalohexis Targets Metabolic ‘Thermostat’ to Treat Obesity a... Read Post »
Health TidingsEvotec–BMS Molecular Glue Candidate BMS-986506 Enters Phase 1 Trial Evotec–BMS Molecular Glue Candidate BMS-986506 Enters Phase 1 Trial Read Post »
Health Tidings Policy & AcquisitionsWhat Is FDA’s New Approach Methodologies (NAMs) Framework for Non-Animal ... What Is FDA’s New Approach Methodologies (NAMs) Framework for Non-Animal ... Read Post »
Lifestyle WellnessCortisol Detox: Can You Really Reset Your Stress Hormones? Cortisol Detox: Can You Really Reset Your Stress Hormones? Read Post »
New Drug ApprovalWegovy HD Approved by FDA After Trials Show ~21% Weight Loss Wegovy HD Approved by FDA After Trials Show ~21% Weight Loss Read Post »
Health TidingsSarepta Plans sNDA Submissions for Full Approval of DMD Therapies AMONDYS 4... Sarepta Plans sNDA Submissions for Full Approval of DMD Therapies AMONDYS 4... Read Post »
Health TidingsLilly’s Retatrutide Shows Up to 2.0% A1C Reduction and 16.8% Weight Loss ... Lilly’s Retatrutide Shows Up to 2.0% A1C Reduction and 16.8% Weight Loss ... Read Post »
New Drug ApprovalFDA Approves GSK’s Lynavoy as First Treatment for PBC-Related Itch FDA Approves GSK’s Lynavoy as First Treatment for PBC-Related Itch Read Post »
Clinical TrialsPfizer’s TALZENNA Combo Hits rPFS Goal in TALAPRO-3 Pfizer’s TALZENNA Combo Hits rPFS Goal in TALAPRO-3 Read Post »
Drugs Safety AlertEisai Pulls Tazverik in Japan After Global Safety Review Eisai Pulls Tazverik in Japan After Global Safety Review Read Post »
Health TidingsPriavoid Reports Low ARIA Rates for Oral Alzheimer’s Drug PRI-002 Priavoid Reports Low ARIA Rates for Oral Alzheimer’s Drug PRI-002 Read Post »
Clinical TrialsSobi Explores Gamifant for Interferon-Gamma–Driven Sepsis in New Phase 2a... Sobi Explores Gamifant for Interferon-Gamma–Driven Sepsis in New Phase 2a... Read Post »
Health TidingsCSL Works to Restore Hemgenix Supply Amid Temporary Global Stockout CSL Works to Restore Hemgenix Supply Amid Temporary Global Stockout Read Post »
ResearchGrifols Detects Parkinson’s Disease Changes Years Before Diagnosis Grifols Detects Parkinson’s Disease Changes Years Before Diagnosis Read Post »
Health TidingsSanofi Receives U.S. FDA Breakthrough Therapy Designation for Venglustat fo... Sanofi Receives U.S. FDA Breakthrough Therapy Designation for Venglustat fo... Read Post »
New Drug ApprovalJ&J’s Oral IL-23 Therapy ICOTYDE Wins FDA Approval for Plaque Psorias... J&J’s Oral IL-23 Therapy ICOTYDE Wins FDA Approval for Plaque Psorias... Read Post »
GenericsZydus Expands Semaglutide Reach in India Through Co-Marketing Deals with To... Zydus Expands Semaglutide Reach in India Through Co-Marketing Deals with To... Read Post »
Clinical TrialsRhythm’s EMANATE Misses Endpoint, Highlights Subgroup Benefit Rhythm’s EMANATE Misses Endpoint, Highlights Subgroup Benefit Read Post »
Mergers & AcquisitionsSandoz Bets on $320B Biosimilar Opportunity with New Samsung Bioepis Partne... Sandoz Bets on $320B Biosimilar Opportunity with New Samsung Bioepis Partne... Read Post »
Health TidingsIllumina, Veritas Team Up to Integrate Preventive Genomics in Healthcare Illumina, Veritas Team Up to Integrate Preventive Genomics in Healthcare Read Post »
Health TidingsChina Speeds Review of Gyre’s Hydronidone China Speeds Review of Gyre’s Hydronidone Read Post »
Health TidingsSarepta Initiates New ENDEAVOR Cohort to Reduce ELEVIDYS Liver Toxicity Ris... Sarepta Initiates New ENDEAVOR Cohort to Reduce ELEVIDYS Liver Toxicity Ris... Read Post »
Clinical TrialsPfizer’s Next-Gen CDK4 Inhibitor Shows Phase 2 Breast Cancer Benefit Pfizer’s Next-Gen CDK4 Inhibitor Shows Phase 2 Breast Cancer Benefit Read Post »
Clinical TrialsFDA Finds No Bioequivalence Deficiencies in NRx Preservative-Free Ketamine ... FDA Finds No Bioequivalence Deficiencies in NRx Preservative-Free Ketamine ... Read Post »
Health TidingsAldeyra Receives FDA Complete Response Letter for Reproxalap, Citing Lack o... Aldeyra Receives FDA Complete Response Letter for Reproxalap, Citing Lack o... Read Post »
Drugs Safety AlertSCFE Cases Prompt BioMarin to Halt Select VOXZOGO Trials in Rare Growth Dis... SCFE Cases Prompt BioMarin to Halt Select VOXZOGO Trials in Rare Growth Dis... Read Post »
Health Tidings Policy & AcquisitionsZydus’ Sentynl Licenses Progerinin from PRG S&T to Advance Rare Disea... Zydus’ Sentynl Licenses Progerinin from PRG S&T to Advance Rare Disea... Read Post »
Health TidingsSun Pharma’s ILUMYA sBLA Accepted by FDA for Psoriatic Arthritis Sun Pharma’s ILUMYA sBLA Accepted by FDA for Psoriatic Arthritis Read Post »
Clinical TrialsStructure Therapeutics’ Aleniglipron Demonstrates Strong Weight Loss Structure Therapeutics’ Aleniglipron Demonstrates Strong Weight Loss Read Post »
Health TidingsLilly Expands Affordable Access to Zepbound KwikPen for Weight Management Lilly Expands Affordable Access to Zepbound KwikPen for Weight Management Read Post »
Clinical TrialsLilly Advances EBGLYSS Pediatric Indication After Positive ADorable-1 Trial... Lilly Advances EBGLYSS Pediatric Indication After Positive ADorable-1 Trial... Read Post »
Clinical TrialsCytomX Eyes Registrational Path for Varseta-M After Encouraging CRC Data CytomX Eyes Registrational Path for Varseta-M After Encouraging CRC Data Read Post »
Clinical TrialsBayer Reports Positive Phase III FIND-CKD Results for Finerenone Bayer Reports Positive Phase III FIND-CKD Results for Finerenone Read Post »
